A 66-year-old female has normal calcium, elevated PTH, low phosphate, and raised ALP. What is the diagnosis?

AIIMS Nagpur NO - 2018

Applied Biochemistry (E5)

Hard

Appeared in: AIIMS Nagpur NO - 2018

Explanation

The patient's lab profile (normal calcium, elevated PTH, low phosphate, high ALP) is a classic presentation of secondary hyperparathyroidism.
Vitamin D deficiency is the most common cause of secondary hyperparathyroidism.
In this condition, low vitamin D impairs calcium absorption, causing PTH to rise in compensation.
The elevated PTH maintains normal calcium levels at the expense of the skeleton (raising ALP) and by increasing phosphate excretion in the kidneys (lowering phosphate).

Option A: Primary hyperparathyroidism is characterized by autonomous PTH secretion that leads to hypercalcemia (high calcium). The patient's calcium level is normal.
Option C: Hypoparathyroidism is defined by deficient PTH secretion. This patient has elevated PTH levels.
Option D: In chronic kidney disease, the kidneys fail to excrete phosphate, leading to hyperphosphatemia (high phosphate). This patient has low phosphate.

Visual 1: Flowchart: A diagram illustrating the pathophysiology of Vitamin D deficiency, showing how it leads to decreased calcium absorption, which triggers an increase in PTH, resulting in low phosphate and high ALP while maintaining normal calcium.
Visual 2: Table: A comparative table showing the typical lab findings (Calcium, PTH, Phosphate, ALP) in primary hyperparathyroidism, secondary hyperparathyroidism (due to vitamin D deficiency and CKD), and hypoparathyroidism.

Clinical Relevance

Nursing practice connection: Use the key finding related to Interpretation of biochemical markers in metabolic bone disease to guide bedside assessment, documentation, and the next nursing action.
Differentiating between primary and secondary hyperparathyroidism is crucial for treatment. Secondary hyperparathyroidism is managed by treating the underlying cause, such as by providing vitamin D supplementation.
Nurses should monitor for signs of hypocalcemia (like tingling, muscle cramps, or tetany) in patients with severe vitamin D deficiency, as their compensatory mechanisms might fail.
Patient education is key, especially for elderly individuals, regarding adequate sunlight exposure and dietary intake of vitamin D and calcium to prevent this condition.

How to Approach the Question

First, identify the core abnormal lab value: elevated PTH. This immediately points towards a condition involving parathyroid gland overactivity.
Next, analyze the serum calcium level. It is normal. This is a critical clue suggesting a compensatory (secondary) process rather than a primary gland tumor (which usually causes high calcium).
Then, examine the phosphate level. It is low. This is consistent with the known effect of PTH, which increases phosphate excretion by the kidneys.
Finally, evaluate each option against this specific lab pattern (High PTH, Normal Ca, Low PO4):
Primary hyperparathyroidism? No, calcium is usually high.
Vitamin D deficiency? Yes, it perfectly explains this pattern of secondary hyperparathyroidism.

Concept Tested & Keywords

Concept Tested: Interpretation of biochemical markers in metabolic bone disease
Stem keywords: normal calcium, elevated PTH, low phosphate, raised ALP
Lead-in keywords: What is the diagnosis?
Clinical cues: The combination of normal calcium with high PTH is a key indicator of a secondary, or compensated, process.

QbHwd9uAXhoIOPyZmBeVVP